Lista de obras -

A phase II study of the efficacy and safety of the combination therapy of the MEK inhibitor refametinib (BAY 86-9766) plus sorafenib for Asian patients with unresectable hepatocellular carcinoma.

artículo científico publicado en 2014

A protein-based set of reference markers for liver tissues and hepatocellular carcinoma

artículo científico publicado en 2009

Advanced pancreatic cancer: flourishing novel approaches in the era of biological therapy.

artículo científico publicado en 2014

Allograft inflammatory factor-1 (AIF-1) is crucial for the survival and pro-inflammatory activity of macrophages

scientific journal article

Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma

artículo científico publicado en 2010

Biology of hepatocellular carcinoma

artículo científico publicado en 2008

Circulating oncometabolite 2-hydroxyglutarate is a potential surrogate biomarker in patients with isocitrate dehydrogenase-mutant intrahepatic cholangiocarcinoma

artículo científico publicado en 2014

Clinical implications of angiogenesis in cancers

artículo científico publicado en 2006

Clinicopathologic and gene expression parameters predict liver cancer prognosis.

artículo científico publicado en 2011

Clinicopathological and prognostic significance of serum and tissue Dickkopf-1 levels in human hepatocellular carcinoma.

artículo científico publicado en 2011

Combined resection and radiofrequency ablation for multifocal hepatocellular carcinoma: prognosis and outcomes

artículo científico publicado en 2010

Comparative proteomic analysis of mouse livers from embryo to adult reveals an association with progression of hepatocellular carcinoma

artículo científico publicado en 2008

Consensus recommendations and review by an International Expert Panel on Interventions in Hepatocellular Carcinoma (EPOIHCC).

artículo científico

DLK1-DIO3 Genomic Imprinted MicroRNA Cluster at 14q32.2 Defines a Stemlike Subtype of Hepatocellular Carcinoma Associated with Poor Survival ⬇️

artículo científico publicado el 7 de julio de 2011

DNA damage mediated s and g(2) checkpoints in human embryonal carcinoma cells

artículo científico publicado en 2009

Emergence of CD26+ Cancer Stem Cells with Metastatic Properties in Colorectal Carcinogenesis.

artículo científico publicado en 2017

Enhanced detection of early hepatocellular carcinoma by serum SELDI-TOF proteomic signature combined with alpha-fetoprotein marker.

artículo científico publicado en 2010

G1 checkpoint establishment in vivo during embryonic liver development.

artículo científico publicado en 2014

Gene signatures derived from a c-MET-driven liver cancer mouse model predict survival of patients with hepatocellular carcinoma

artículo científico publicado en 2011

Genome-wide association study of hepatocellular carcinoma in Southern Chinese patients with chronic hepatitis B virus infection.

artículo científico publicado en 2011

Genomic profiling of intrahepatic cholangiocarcinoma: refining prognosis and identifying therapeutic targets

artículo científico publicado en 2014

Good longterm survival after primary living donor liver transplantation for solitary hepatocellular carcinomas up to 8 cm in diameter.

artículo científico publicado en 2014

Hepatectomy for hepatocellular carcinoma with major portal or hepatic vein invasion: results of a multicenter study

artículo científico publicado en 2005

Hepatitis B virus full-length genomic mutations and quasispecies in hepatocellular carcinoma

artículo científico publicado en 2016

Improving perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases: analysis of 1222 consecutive patients from a prospective database

artículo científico publicado en 2004

Little girl who conquered the "ALPPS''.

artículo científico publicado en 2014

Lyso-thermosensitive liposomal doxorubicin: a novel approach to enhance efficacy of thermal ablation of liver cancer

artículo científico publicado en 2009

Occult hepatitis B infection and HBV replicative activity in patients with cryptogenic cause of hepatocellular carcinoma.

artículo científico publicado en 2011

Oncofetal gene SALL4 in aggressive hepatocellular carcinoma

artículo científico publicado en 2013

Oncoproteomics of hepatocellular carcinoma: from cancer markers' discovery to functional pathways.

artículo científico publicado en 2007

Osteopontin Overexpression Induced Tumor Progression and Chemoresistance to Oxaliplatin through Induction of Stem-Like Properties in Human Colorectal Cancer

artículo científico publicado en 2015

Phase I study investigating everolimus combined with sorafenib in patients with advanced hepatocellular carcinoma

artículo científico publicado en 2013

Post-operative plasma osteopontin predicts distant metastasis in human colorectal cancer

artículo científico publicado en 2015

Predicting prognosis in hepatocellular carcinoma after curative surgery with common clinicopathologic parameters.

artículo científico publicado en 2009

Predictive genes in adjacent normal tissue are preferentially altered by sCNV during tumorigenesis in liver cancer and may rate limiting

artículo científico publicado en 2011

Proline-rich tyrosine kinase 2 (Pyk2) promotes cell motility of hepatocellular carcinoma through induction of epithelial to mesenchymal transition

artículo científico publicado en 2011

Proline-rich tyrosine kinase 2 (Pyk2) promotes proliferation and invasiveness of hepatocellular carcinoma cells through c-Src/ERK activation

artículo científico publicado en 2008

Prophylactic uses of integrin CD18-betaA peptide in a murine polymicrobial peritonitis model

artículo científico publicado en 2010

Proteomic expression signature distinguishes cancerous and nonmalignant tissues in hepatocellular carcinoma

artículo científico publicado en 2009

Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial

artículo científico publicado en 2015

Re-evaluating transarterial chemoembolization for the treatment of hepatocellular carcinoma: Consensus recommendations and review by an International Expert Panel.

artículo científico publicado en 2013

Risk Factors and Post-Resection Independent Predictive Score for the Recurrence of Hepatitis B-Related Hepatocellular Carcinoma ⬇️

artículo científico publicado en 2016

Safety limit of large-volume hepatic radiofrequency ablation in a rat model

artículo científico publicado en 2006

Significance of CD90+ cancer stem cells in human liver cancer

artículo científico publicado en 2008

Suppression of Slit3 induces tumor proliferation and chemoresistance in hepatocellular carcinoma through activation of GSK3β/β-catenin pathway.

artículo científico publicado en 2018

Suppression of actopaxin impairs hepatocellular carcinoma metastasis through modulation of cell migration and invasion.

artículo científico publicado en 2013

Survival analysis of high-intensity focused ultrasound ablation in patients with small hepatocellular carcinoma

artículo científico publicado en 2012

Survivin depletion inhibits tumor growth and enhances chemosensitivity in hepatocellular carcinoma.

artículo científico publicado en 2014

The Enhanced metastatic potential of hepatocellular carcinoma (HCC) cells with sorafenib resistance

artículo científico publicado en 2013

The Role of Proline Rich Tyrosine Kinase 2 (Pyk2) on Cisplatin Resistance in Hepatocellular Carcinoma ⬇️

artículo científico publicado el 9 de noviembre de 2011

The clinicopathological significance of miR-133a in colorectal cancer

artículo científico publicado en 2014

The use of single-agent sorafenib in the treatment of advanced hepatocellular carcinoma patients with underlying Child-Pugh B liver cirrhosis: a retrospective analysis of efficacy, safety, and survival benefits

artículo científico publicado en 2012

Tolerance of high-intensity focused ultrasound ablation in patients with hepatocellular carcinoma

artículo científico publicado en 2012

Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma

artículo científico publicado en 2009

microRNA-122 as a regulator of mitochondrial metabolic gene network in hepatocellular carcinoma

artículo científico publicado en 2010

Lista de obras de

A phase II study of the efficacy and safety of the combination therapy of the MEK inhibitor refametinib (BAY 86-9766) plus sorafenib for Asian patients with unresectable hepatocellular carcinoma.

A protein-based set of reference markers for liver tissues and hepatocellular carcinoma

Advanced pancreatic cancer: flourishing novel approaches in the era of biological therapy.

Allograft inflammatory factor-1 (AIF-1) is crucial for the survival and pro-inflammatory activity of macrophages

Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma

Biology of hepatocellular carcinoma

Circulating oncometabolite 2-hydroxyglutarate is a potential surrogate biomarker in patients with isocitrate dehydrogenase-mutant intrahepatic cholangiocarcinoma

Clinical implications of angiogenesis in cancers

Clinicopathologic and gene expression parameters predict liver cancer prognosis.

Clinicopathological and prognostic significance of serum and tissue Dickkopf-1 levels in human hepatocellular carcinoma.

Combined resection and radiofrequency ablation for multifocal hepatocellular carcinoma: prognosis and outcomes

Comparative proteomic analysis of mouse livers from embryo to adult reveals an association with progression of hepatocellular carcinoma

Consensus recommendations and review by an International Expert Panel on Interventions in Hepatocellular Carcinoma (EPOIHCC).

DLK1-DIO3 Genomic Imprinted MicroRNA Cluster at 14q32.2 Defines a Stemlike Subtype of Hepatocellular Carcinoma Associated with Poor Survival ⬇️

DNA damage mediated s and g(2) checkpoints in human embryonal carcinoma cells

Emergence of CD26+ Cancer Stem Cells with Metastatic Properties in Colorectal Carcinogenesis.

Enhanced detection of early hepatocellular carcinoma by serum SELDI-TOF proteomic signature combined with alpha-fetoprotein marker.

G1 checkpoint establishment in vivo during embryonic liver development.

Gene signatures derived from a c-MET-driven liver cancer mouse model predict survival of patients with hepatocellular carcinoma

Genome-wide association study of hepatocellular carcinoma in Southern Chinese patients with chronic hepatitis B virus infection.

Genomic profiling of intrahepatic cholangiocarcinoma: refining prognosis and identifying therapeutic targets

Good longterm survival after primary living donor liver transplantation for solitary hepatocellular carcinomas up to 8 cm in diameter.

Hepatectomy for hepatocellular carcinoma with major portal or hepatic vein invasion: results of a multicenter study

Hepatitis B virus full-length genomic mutations and quasispecies in hepatocellular carcinoma

Improving perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases: analysis of 1222 consecutive patients from a prospective database

Little girl who conquered the "ALPPS''.

Lyso-thermosensitive liposomal doxorubicin: a novel approach to enhance efficacy of thermal ablation of liver cancer

Occult hepatitis B infection and HBV replicative activity in patients with cryptogenic cause of hepatocellular carcinoma.

Oncofetal gene SALL4 in aggressive hepatocellular carcinoma

Oncoproteomics of hepatocellular carcinoma: from cancer markers' discovery to functional pathways.

Osteopontin Overexpression Induced Tumor Progression and Chemoresistance to Oxaliplatin through Induction of Stem-Like Properties in Human Colorectal Cancer

Phase I study investigating everolimus combined with sorafenib in patients with advanced hepatocellular carcinoma

Post-operative plasma osteopontin predicts distant metastasis in human colorectal cancer

Predicting prognosis in hepatocellular carcinoma after curative surgery with common clinicopathologic parameters.

Predictive genes in adjacent normal tissue are preferentially altered by sCNV during tumorigenesis in liver cancer and may rate limiting

Proline-rich tyrosine kinase 2 (Pyk2) promotes cell motility of hepatocellular carcinoma through induction of epithelial to mesenchymal transition

Proline-rich tyrosine kinase 2 (Pyk2) promotes proliferation and invasiveness of hepatocellular carcinoma cells through c-Src/ERK activation

Prophylactic uses of integrin CD18-betaA peptide in a murine polymicrobial peritonitis model

Proteomic expression signature distinguishes cancerous and nonmalignant tissues in hepatocellular carcinoma

Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial

Re-evaluating transarterial chemoembolization for the treatment of hepatocellular carcinoma: Consensus recommendations and review by an International Expert Panel.

Risk Factors and Post-Resection Independent Predictive Score for the Recurrence of Hepatitis B-Related Hepatocellular Carcinoma ⬇️

Safety limit of large-volume hepatic radiofrequency ablation in a rat model

Significance of CD90+ cancer stem cells in human liver cancer

Suppression of Slit3 induces tumor proliferation and chemoresistance in hepatocellular carcinoma through activation of GSK3β/β-catenin pathway.

Suppression of actopaxin impairs hepatocellular carcinoma metastasis through modulation of cell migration and invasion.

Survival analysis of high-intensity focused ultrasound ablation in patients with small hepatocellular carcinoma

Survivin depletion inhibits tumor growth and enhances chemosensitivity in hepatocellular carcinoma.

The Enhanced metastatic potential of hepatocellular carcinoma (HCC) cells with sorafenib resistance

The Role of Proline Rich Tyrosine Kinase 2 (Pyk2) on Cisplatin Resistance in Hepatocellular Carcinoma ⬇️

The clinicopathological significance of miR-133a in colorectal cancer

The use of single-agent sorafenib in the treatment of advanced hepatocellular carcinoma patients with underlying Child-Pugh B liver cirrhosis: a retrospective analysis of efficacy, safety, and survival benefits

Tolerance of high-intensity focused ultrasound ablation in patients with hepatocellular carcinoma

Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma

microRNA-122 as a regulator of mitochondrial metabolic gene network in hepatocellular carcinoma